Core Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Core pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Core Pharma Today - Breaking & Trending Today

IFF Reports Fourth Quarter and Full Year 2023 Results

International Flavors & Fragrances Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.

Fourth Quarter 2023 Consolidated. ....

United Kingdom , Erik Fyrwald , Pharma Solutions Segment , Global Shared Services Centers , Company Annual Report On Form , Savory Solutions , Health Biosciences Segment , International Flavors Fragrances Inc , European Union , Health Wright Products , Pharma Solutions , Comparable Foreign Exchange Impact , Health Biosciences , International Flavors , Functional Ingredients , Consumer Fragrance , Food Design , Locust Bean Kernel , Food Enzymes , Personal Care , Grain Processing , Fine Fragrance , Core Pharma , Fragrance Ingredients , Consolidated Statements , Comprehensive Loss ,

Strides Board approves demerger of its Biotech business under Stelis Biopharma

Strides Board approves demerger of its Biotech business under Stelis Biopharma
Bengaluru, Feb 4 (UNI) Strides Pharma Science Limited (Strides), Bengaluru headquartered global Pharmaceutical Company on Thursday announced that its Board of Directors have approved in principle the demerger of its biotech business under Stelis Biopharma (Stelis).
The demerger is expected to unlock significant value for Strides shareholders.
A Committee will be formed to explore various options of value discovery including listing of the business on a standalone basis and recommend to the Audit Committee, Committee of Independent Directors and Board including the Scheme, swap ratio and way forward, according to a release here on Thursday. ....

Stelis Biopharmabengaluru , Aditya Puri , Stelis Biopharma , Committee Of Independent Directors , Company On , Strides Pharma Science Limited , A Committee , Audit Committee , Pharmaceutical Company , Independent Directors , Core Pharma , Stelis Biopharma Board , Managing Director , Chief Executive Officer , குழு ஆஃப் சுயாதீனமான இயக்குநர்கள் , நிறுவனம் ஆன் , முன்னேற்றங்கள் பார்மா அறிவியல் வரையறுக்கப்பட்டவை , தணிக்கை குழு , மருந்து நிறுவனம் , சுயாதீனமான இயக்குநர்கள் , கோர் பார்மா , நிர்வகித்தல் இயக்குனர் , தலைமை நிர்வாகி அதிகாரி ,

Aditya Puri to Chair the Board of Stelis Biopharma, the proposed demerged Biotech Business of Strides

Aditya Puri to Chair the Board of Stelis Biopharma, the proposed demerged Biotech Business of Strides
Posted On:
2021-02-04 01:37:49
(Time Zone: Arizona, USA)
Strides Pharma Science Limited (Strides) today announced that the Board of Directors of the Company have approved in principle the demerger of its biotech business under Stelis Biopharma (Stelis). The demerger is expected to unlock significant value for Strides shareholders.
The Board will form a Committee of Directors to explore various options of value discovery including listing of the business on a standalone basis. The Committee will recommend the proposals to the Audit Committee, Committee of Independent Directors and Board including the Scheme, swap ratio and way forward. ....

United States , Aditya Puri , Stelis Biopharma , Committee Of Independent Directors , Strides Pharma Science Ltd , Strides Pharma Science Limited , Committee Of Directors , Audit Committee , Board Of Directors The Company , Biotech Business , Time Zone , Pharma Science Limited , Independent Directors , Core Pharma , Puri Joins , Stelis Biopharma Board , Managing Director , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , குழு ஆஃப் சுயாதீனமான இயக்குநர்கள் , முன்னேற்றங்கள் பார்மா அறிவியல் லிமிடெட் , முன்னேற்றங்கள் பார்மா அறிவியல் வரையறுக்கப்பட்டவை , குழு ஆஃப் இயக்குநர்கள் , தணிக்கை குழு , பலகை ஆஃப் இயக்குநர்கள் தி நிறுவனம் , பயோடெக் வணிக ,